HYLORIS PHARMACEUTICALS SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.7 EUR | -1.27% |
|
-2.50% | -8.24% |
| Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
| Mar. 14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
Evolution of the average Target Price on Hyloris Pharmaceuticals SA
Price target over the last 5 years
History of analyst recommendation changes
356132b02ebdd2f835946.9Gc6fyknJZ8agyDZbVxpG6ENcLMzVFVq4lhvS4D6iOE.hTV4ShFJZ9JO8m_tGwsLSZJdMd5lIng-tBMsePi45q3HPn1NeHFwy0XTVw~50b634498355469df4fbc0ed3db90fb9
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
11.7
EUR
Average target price
21.55
EUR
Spread / Average Target
+84.19%
High Price Target
22.1
EUR
Spread / Highest target
+88.89%
Low Price Target
21
EUR
Spread / Lowest Target
+79.49%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- HYL Stock
- Consensus Hyloris Pharmaceuticals SA
